M5R
5-{(7R)-1-fluoro-3-hydroxy-7-[(3-methylbutyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yl}-1lambda~6~,2,5-thiadiazolidine-1,1,3-trione
| Created: | 2022-03-14 |
| Last modified: | 2023-07-26 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 50 |
| Chiral Atom Count | 1 |
| Bond Count | 52 |
| Aromatic Bond Count | 6 |
Chemical Component Summary | |
|---|---|
| Name | 5-{(7R)-1-fluoro-3-hydroxy-7-[(3-methylbutyl)amino]-5,6,7,8-tetrahydronaphthalen-2-yl}-1lambda~6~,2,5-thiadiazolidine-1,1,3-trione |
| Systematic Name (OpenEye OEToolkits) | 5-[(7~{R})-1-fluoranyl-7-(3-methylbutylamino)-3-oxidanyl-5,6,7,8-tetrahydronaphthalen-2-yl]-1,1-bis(oxidanylidene)-1,2,5-thiadiazolidin-3-one |
| Formula | C17 H24 F N3 O4 S |
| Molecular Weight | 385.454 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | O=C1CN(c2c(F)c3CC(NCCC(C)C)CCc3cc2O)S(=O)(=O)N1 |
| SMILES | CACTVS | 3.385 | CC(C)CCN[CH]1CCc2cc(O)c(N3CC(=O)N[S]3(=O)=O)c(F)c2C1 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CC(C)CCNC1CCc2cc(c(c(c2C1)F)N3CC(=O)NS3(=O)=O)O |
| Canonical SMILES | CACTVS | 3.385 | CC(C)CCN[C@@H]1CCc2cc(O)c(N3CC(=O)N[S]3(=O)=O)c(F)c2C1 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CC(C)CCN[C@@H]1CCc2cc(c(c(c2C1)F)N3CC(=O)NS3(=O)=O)O |
| InChI | InChI | 1.03 | InChI=1S/C17H24FN3O4S/c1-10(2)5-6-19-12-4-3-11-7-14(22)17(16(18)13(11)8-12)21-9-15(23)20-26(21,24)25/h7,10,12,19,22H,3-6,8-9H2,1-2H3,(H,20,23)/t12-/m1/s1 |
| InChIKey | InChI | 1.03 | DVFCRTGTEXUFIN-GFCCVEGCSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB21547 |
|---|---|
| Name | Osunprotafib |
| Groups | investigational |
| Description | Osunprotafib is a small molecule drug. The usage of the INN stem '-protafib' in the name indicates that Osunprotafib is a human protein tyrosine phosphatase (HPTP) inhibitor. Osunprotafib is under investigation in clinical trial NCT04777994 (Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors). Osunprotafib has a monoisotopic molecular weight of 385.15 Da. |
| Synonyms |
|
| Categories |
|
| CAS number | 2489404-97-7 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 155103607 |
| ChEMBL | CHEMBL5095164 |














